scholarly journals A Case Of Vena Cava Superior Syndrome With Lymphoma

2020 ◽  
pp. 232-236
Author(s):  
Lale SERTÇELİK ◽  
Fatma Armağan HAZAR ◽  
Mine DEMİR ◽  
İpek ERDEM ◽  
Aysun KOSİF
Keyword(s):  
Vena Cava ◽  
Vena Cava Superior ◽  
Vena Cava Superior Syndrome

P0350 BLASTIC NK CELL LYMPHOMA/LEUKEMIA PRESENTING WITH VENA CAVA SUPERIOR SYNDROME: CASE REPORT

2009 ◽  
Vol 20 ◽  
pp. S120
Author(s):  
Ayse Nur Tufan ◽  
Omer Kaya ◽  
Hande Bektas ◽  
Fatih Tufan ◽  
Selim Yavuz ◽  
...  
Keyword(s):  
Case Report ◽  
Nk Cell ◽  
Cell Lymphoma ◽  
Vena Cava ◽  
Vena Cava Superior ◽  
Vena Cava Superior Syndrome

scholarly journals Malignant Wegener’s Granulomatosis with Fibrosing Mediastinitis and Vena Cava Superior Syndrome

Renal Failure ◽  
2012 ◽  
Vol 34 (2) ◽  
pp. 244-246 ◽  
Author(s):  
Karel Matousovic ◽  
Vojtech Martinek ◽  
Jaroslav Špatenka ◽  
Josef Stejskal ◽  
Maria Chadimova
Keyword(s):  
Wegener’S Granulomatosis ◽  
Vena Cava ◽  
Wegener's Granulomatosis ◽  
Fibrosing Mediastinitis ◽  
Vena Cava Superior ◽  
Vena Cava Superior Syndrome

Vena Cava Superior Syndrome

2021 ◽  
Vol 8 (3) ◽  
pp. 61-69
Author(s):  
Aysegul YILDIRIM ◽  
Keyword(s):  
Vena Cava ◽  
Vena Cava Superior ◽  
Vena Cava Superior Syndrome

scholarly journals Lung Cancer Patients’ Profile in Dr Soetomo General Hospital Surabaya 2016 - 2017: Newest Report

2019 ◽  
Vol 10 (1) ◽  
pp. 44
Author(s):  
Sita Ro'yul Aini ◽  
Laksmi Wulandari ◽  
Susilowati Andajani
Keyword(s):  
Lung Cancer ◽  
Cancer Patients ◽  
General Hospital ◽  
Egfr Mutation ◽  
Vena Cava ◽  
Men And Women ◽  
Lung Cancer Patients ◽  
Active Smoker ◽  
Vena Cava Superior ◽  
Vena Cava Superior Syndrome

A B S T R A C TMethods: This research was a descriptive observational study. The samples were 240 patients of lung cancer in Poly Oncology Dr. Soetomo General Hospital Surabaya 2016-2017. Sampling technique was non-random sampling (consecutive sampling). The variables were: age, sex, smoking habits, type of lung cancer, type of mutation, stage, symptoms, Vena Cava Superior syndrome, and therapy. The data analyzed were analyzed descriptively.Results: Patients mostly at age 51-55 and 56-60 years old (18% each). Ratio men and women are 1,7:1. In all type of lung cancer, men are dominant than women and mostly patients is active smoker. Ephidermal Growth Factor Receptor (EGFR) mutation found in adenosquamous (75%) and adenocarcinoma (65%). Most patients diagnosed at advance stage. Most symptoms are cough (70.4%), dyspnoea (50%), and chest pain (49.2%). Vena Cava Superior Syndrome (VCSS) found in adenocarcinoma (75%) and squamous cell carcinoma (25%). In adenocarcinoma and adenosquamous, patients commonly got targeted therapy.Conclusion: Lung cancer patients: 1) Men tend to be exposed to younger than women, 2) ratio men and women is 1.7:1 and most type in lung cancer is adenocarcinoma 3) mostly patients is active smoker, 4) EGFR mutation tent to be in women with adenocarcinoma, 5) most stage is stage IV, 6) most symptoms is cough, 7) Vena Cava Superior Syndrome is in adenocarcinoma (75%) and carcinoma cell squamous (25%), 8) patients’ therapy mostly with targeted therapy followed by chemotherapy.

scholarly journals The Use of Kolcaba Comfort Theory in Nursing Management of a Patient with Vena Cava Superior Syndrome

2021 ◽  
Vol 12 (28) ◽  
pp. 134-140
Author(s):  
Berna Cafer Karalar ◽  
◽  
Canan Bozkurt ◽  
Turkan Caliskan ◽  
Yasemin Yildirim ◽  
...  
Keyword(s):  
Vena Cava ◽  
Nursing Management ◽  
Vena Cava Superior ◽  
Vena Cava Superior Syndrome ◽  
Comfort Theory
Sign in / Sign up

Export Citation Format

Share Document